Altered microRNA expression of nasal mucosa in long-term asthma and allergic rhinitis

International Archives of Allergy and Immunology

Volumn 163, Issue 3, 2014, Pages 168-178

  Suojalehto, Hille ^a   Lindström, Irmeli ^a   Majuri, Marja Leena ^b   Mitts, Camilla ^b   Karjalainen, Jouko ^c   Wolff, Henrik ^b   Alenius, Harri ^b  

^a Control of Hypersensitivity Diseases Team ^*  (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c Centre of Military Medicine   (Finland)

Author keywords

Allergic rhinitis; Asthma; Biomarkers; Cytokines; MicroRNA

Indexed keywords

CYTOKINE; MICRORNA; MICRORNA 126; MICRORNA 143; MICRORNA 155; NITRIC OXIDE; LET 7E; MICRORNA 187; MICRORNA 18A; MICRORNA 224; MICRORNA 498; MICRORNA 886 3P; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EOSINOPHIL; HUMAN; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; NASAL BIOPSY; NOSE MUCOSA; PRIORITY JOURNAL; UPREGULATION; HISTOLOGY; HUMAN TISSUE; MIDDLE AGED; PROTEIN EXPRESSION;

ADULT; ASTHMA; CHRONIC DISEASE; CYTOKINES; HUMANS; IMMUNOGLOBULIN E; MALE; MICRORNAS; MIDDLE AGED; NASAL MUCOSA; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY FUNCTION TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS, ALLERGIC, PERENNIAL;

EID: 84893696845     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000358486     Document Type: Article

References (55)

1. Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-478.
2. Pallasaho P, Juusela M, Lindqvist A, Sovijarvi A, Lundback B, Ronmark E: Allergic rhinoconjunctivitis doubles the risk for incident asthma -results from a population study in Helsinki, Finland. Respir Med 2011; 105: 1449-1456.
3. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Ait-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(suppl 86):8-160.
4. Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J, Ohta K, Price D, Bousquet J: Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2) LEN. Allergy 2007; 62(suppl 84):1-41.
5. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F: Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects -results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 104: 301-304.
6. Magnan A, Meunier JP, Saugnac C, Gasteau J, Neukirch F: Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study. Allergy 2008; 63: 292-298.
7. Ponte EV, Franco R, Nascimento HF, Souza-Machado A, Cunha S, Barreto ML, Naspitz C, Cruz AA: Lack of control of severe asthma is associated with co-existence of moderate-tosevere rhinitis. Allergy 2008; 63: 564-569.
8. de Marco R, Marcon A, Jarvis D, Accordini S, Almar E, Bugiani M, Carolei A, Cazzoletti L, Corsico A, Gislason D, Gulsvik A, Jogi R, Marinoni A, Martinez-Moratalla J, Pin I, Janson C: Prognostic factors of asthma severity: a 9-year international prospective cohort study. J Allergy Clin Immunol 2006; 117: 1249-1256.
9. Antonicelli L, Braschi MC, Bresciani M, Bonifazi M, Baldacci S, Angino A, Pala AP, Viegi G: The complex link between severity of asthma and rhinitis in mite allergic patients. Respir Med 2013; 107: 23-29.
10. Barnes PJ: Pathophysiology of allergic inflammation. Immunol Rev 2011; 242: 31-50.
11. Togias A: Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003; 111: 1171-1183, quiz 1184.
12. Gaga M, Lambrou P, Papageorgiou N, Koulouris NG, Kosmas E, Fragakis S, Sofios C, Rasidakis A, Jordanoglou J: Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000; 30: 663-669.
13. Lambrou P, Zervas E, Oikonomidou E, Papageorgiou N, Alchanatis M, Gaga M: Eosinophilic infiltration in the nasal mucosa of rhinitis patients: is it affected by the presence of asthma or the allergic status of the patients? Ann Allergy Asthma Immunol 2007; 98: 567-572.
14. Juliusson S, Pipkorn U, Karlsson G, Enerback L: Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992; 90: 898-909.
15. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Bagnasco M, Canonica GW: Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects: relationships with early and late inflammatory phenomena. Am J Respir Crit Care Med 1994; 150: 1653-1659.
16. Milanese M, Ricca V, Canonica GW, Ciprandi G: Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitis. Eur Ann Allergy Clin Immunol 2005; 37: 7-10.
17. Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S, Bagnasco M, Canonica GW: Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995; 96: 971-979.
18. Canonica GW, Compalati E: Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin Exp Immunol 2009; 158: 260-271.
19. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
20. Guo H, Ingolia NT, Weissman JS, Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466: 835-840.
21. Xiao C, Rajewsky K: MicroRNA control in the immune system: basic principles. Cell 2009; 136: 26-36.
22. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D: Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111-122.
23. Lu TX, Rothenberg ME: Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. J Allergy Clin Immunol 2013; 132: 3-13.
24. Rupani H, Sanchez-Elsner T, Howarth P: MicroRNAs and respiratory diseases. Eur Respir J 2013; 41: 695-705.
25. Wang JW, Li K, Hellermann G, Lockey RF, Mohapatra S: Regulating the regulators: microRNA and asthma. World Allergy Organ J 2011; 4: 94-103.
26. Greene CM, Gaughan KP: microRNAs in asthma: potential therapeutic targets. Curr Opin Pulm Med 2013; 19: 66-72.
27. Williams AE, Larner-Svensson H, Perry MM, Campbell GA, Herrick SE, Adcock IM, Erjefalt JS, Chung KF, Lindsay MA: microRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One 2009; 4:e5889.
28. Jiang X: The emerging role of microRNAs in asthma. Mol Cell Biochem 2011; 353: 35-40.
29. Shaoqing Y, Ruxin Z, Guojun L, Zhiqiang Y, Hua H, Shudong Y, Jie Z: Microarray analysis of differentially expressed microRNAs in allergic rhinitis. Am J Rhinol Allergy 2011; 25:e242-e246.
30. Jardim MJ, Dailey L, Silbajoris R, Diaz-Sanchez D: Distinct microRNA expression in human airway cells of asthmatic donors identifies a novel asthma-associated gene. Am J Respir Cell Mol Biol 2012; 47: 536-542.
31. Lindstrom I, Pallasaho P, Luukkonen R, Suojalehto H, Karjalainen J, Lauerma A, Karjalainen A: Reduced work ability in middleaged men with asthma from youth -a 20-year follow-up. Respir Med 2011; 105: 950-955.
32. Lindstrom I, Suojalehto H, Lindholm H, Pallasaho P, Luukkonen R, Karjalainen J, Lauerma A, Karjalainen A: Positive exercise test and obstructive spirometry in young male conscripts associated with persistent asthma 20 years later. J Asthma 2012; 49: 1051-1059.
33. Kilpelainen M, Terho EO, Helenius H, Koskenvuo M: Validation of a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults. Allergy 2001; 56: 377-384.
34. Spector SL, Nicklas RA, Chapman JA, Bernstein IL, Berger WE, Blessing-Moore J, Dykewicz MS, Fineman SM, Lee RE, Li JT, Portnoy JM, Schuller DE, Lang D, Tilles SA: Symptom severity assessment of allergic rhinitis. 1. Ann Allergy Asthma Immunol 2003; 91: 105-114.
35. Liard R, Leynaert B, Zureik M, Beguin FX, Neukirch F: Using global initiative for asthma guidelines to assess asthma severity in populations. Eur Respir J 2000; 16: 615-620.
36. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
37. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
38. Kankkunen P, Rintahaka J, Aalto A, Leino M, Majuri ML, Alenius H, Wolff H, Matikainen S: Trichothecene mycotoxins activate inflammatory response in human macrophages. J Immunol 2009; 182: 6418-6425.
39. Agache I, Akdis C, Jutel M, Virchow JC: Untangling asthma phenotypes and endotypes. Allergy 2012; 67: 835-846.
40. Suojalehto H, Toskala E, Kilpelainen M, Majuri M-L, Mitts C, Lindström I, Puustinen A, Plosila T, Sipilä J, Wolff H, Alenius H: microRNA profiles in nasal mucosa of patients with allergic and nonallergic rhinitis and asthma. Int Forum Allergy Rhinol 201; 3: 612-620.
41. Zhang YN, Cao PP, Zhang XH, Lu X, Liu Z: Expression of microRNA machinery proteins in different types of chronic rhinosinusitis. Laryngoscope 2012; 122: 2621-2627.
42. Navarro A, Valero A, Julia B, Quirce S: Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study. J Investig Allergol Clin Immunol 2008; 18: 233-238.
43. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel F-B: Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
44. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R: The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161: 9-16.
45. Sahin G, Klimek L, Mullol J, Hörmann K, Walther LE, Pfaar O: Nitric oxide: a promising methodological approach in airway diseases. Int Arch Allergy Immunol 2011; 156: 352-361.
46. NO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602-615.
47. Henriksen AH, Sue-Chu M, Holmen TL, Langhammer A, Bjermer L: Exhaled and nasal no levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 1999; 13: 301-306.
48. Shannon J, Ernst P, Yamauchi Y, Olivenstein R, Lemiere C, Foley S, Cicora L, Ludwig M, Hamid Q, Martin JG: Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008; 133: 420-426.
49. Sjogren AK, Barrenas F, Muraro A, Gustafsson M, Saetrom P, Wang H, Benson M: Monozygotic twins discordant for intermittent allergic rhinitis differ in mRNA and protein levels. Allergy 2012; 67: 831-833.
50. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A: Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316: 608-611.
51. Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E: Cutting edge: The Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol 2009; 182: 2578-2582.
52. Martinez-Nunez RT, Louafi F, Sanchez-Elsner T: The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13ralpha1). J Biol Chem 2011; 286: 1786-1794.
53. Mattes J, Collison A, Plank M, Phipps S, Foster PS: Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci USA 2009; 106: 18704-18709.
54. De Flora S, Balansky R, D'Agostini F, Cartiglia C, Longobardi M, Steele VE, Izzotti A: Smoke-induced microRNA and related proteome alterations: Modulation by chemopreventive agents. Int J Cancer 2012; 131; 2763-2773.
55. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, Ergun A, Lu J, Liu G, Zhang X, Bowers J, Vaziri C, Ott K, Sensinger K, Collins JJ, Brody JS, Getts R, Lenburg ME, Spira A: MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA 2009; 106: 2319-2324.